At the Liver Meeting sponsored by the American Association for the Study of Liver Diseases, investigators presented new ...
Researchers at the University of Arizona say a previously unknown population of circulating immune cells play a critical role ...
CNW/ - BirchBioMed Inc., a leading clinical stage biopharmaceutical company, expert in the development of products for ...
Among adults and adolescents with cystic fibrosis starting triple therapy for the first time, inflammatory markers fell and ...
Caleigh has struggled most of her life with a difficult lung disease, but she never lets it get the best of her.
New research out of the University of Iowa is reshaping what it means to live with cystic fibrosis, a genetic disease that ...
FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...
From 2008 to 2023, there has been a significant decrease in cystic fibrosis mortality rates and a significant rise in sickle ...
Semaglutide reduced liver fibrosis and resolved MASH in the ESSENCE trial, offering dual hepatic and metabolic benefits. Read more.
Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback